OZEMPIC COULD DELAY AGEING, RESEARCHERS SUGGEST

Summary from the TLDR newsletter

Semaglutide could be used to slow down the process of aging. A study tracking people aged 45 or older who were overweight and had cardiovascular disease but not diabetes found that those who took the drug died at a lower rate from all causes. It also improved heart failure symptoms and cut levels of inflammation regardless of whether or not people lost weight. The study reinforces the theory that being overweight increases the risk of death due to many etiologies.